Halberd's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Halberd (HALB) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Halberd vs Its Competitors
- Peer revenue share: Halberd accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
HALB Sales vs. its Competitors, Q3 2022
Halberd generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Medical Laboratories industry grew revenue 7.4% year over year, combined, vs 10.6% for Halberd. Halberd's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.